Fieldview Capital Management LLC bought a new position in shares of Humana Inc. (NYSE:HUM – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund bought 4,224 shares of the insurance provider’s stock, valued at approximately $1,082,000.
Other hedge funds have also recently modified their holdings of the company. Long Focus Capital Management LLC bought a new position in shares of Humana during the 3rd quarter worth approximately $34,212,000. AMG National Trust Bank lifted its position in shares of Humana by 106.5% during the 3rd quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock worth $4,411,000 after buying an additional 8,744 shares in the last quarter. Aberdeen Group plc lifted its position in shares of Humana by 18.1% during the 4th quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock worth $72,684,000 after buying an additional 43,442 shares in the last quarter. Alberta Investment Management Corp bought a new position in shares of Humana during the 3rd quarter worth approximately $4,735,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of Humana by 4.1% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock worth $66,207,000 after buying an additional 9,960 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms recently commented on HUM. The Goldman Sachs Group lifted their price target on shares of Humana from $158.00 to $195.00 and gave the stock a “sell” rating in a report on Thursday, April 30th. William Blair initiated coverage on Humana in a research note on Wednesday, May 20th. They issued an “outperform” rating on the stock. Truist Financial upped their price objective on Humana from $270.00 to $320.00 and gave the company a “hold” rating in a research note on Monday, June 1st. Seaport Research Partners downgraded Humana to a “neutral” rating in a research note on Wednesday, May 20th. Finally, JPMorgan Chase & Co. upped their price objective on Humana from $214.00 to $316.00 and gave the company a “neutral” rating in a research note on Monday, June 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, fifteen have given a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $291.35.
Humana Price Performance
Humana stock opened at $379.42 on Monday. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $379.50. The company has a market cap of $45.55 billion, a price-to-earnings ratio of 40.58, a PEG ratio of 2.16 and a beta of 0.76. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The business’s 50 day simple moving average is $267.90 and its 200 day simple moving average is $237.26.
Humana (NYSE:HUM – Get Free Report) last released its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. During the same period in the previous year, the business earned $11.58 EPS. Humana’s revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts forecast that Humana Inc. will post 9.04 EPS for the current year.
Humana Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Humana’s payout ratio is currently 37.86%.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
See Also
- Five stocks we like better than Humana
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
